-
Gospel to over 30 million patients! Good News on New Drugs for Alzheimer's Disease: Eli Lilly executives have "exposed" drug developments in advance: extreme optimism may become the next hot topic similar to weight loss drugs
On Monday (November 6th) Eastern Time, Dr. Daniel Skovoronsky, the chief scientist of Eli Lilly (NYSE: LLC, stock price $595.19, market value $565 billion), the world's highest pharmaceutical company ... -
"Hot and Spicy" Jia Ling drives the demand for weight loss? How big is the gap in the application of new drugs for the expansion of production by giants
From public information, Jia Ling's weight loss mainly relies on controlling her diet and strengthening exercise, which is difficult for many people to persist in for a long time and ultimately leads ... -
US FDA Delays Approval of Eli Lilly's New Drug for Alzheimer's Disease
Lilly Pharmaceuticals announced on March 8th local time that the US Food and Drug Administration (FDA) has notified the company to further understand and evaluate the safety and efficacy of its new A ... -
Can BeiGene PD-1, approved in the United States, grow into the next "blockbuster" level new drug?
After the heavyweight bomb Zebtinib, Baekje has received another ticket to enter the US market for a new drug. On March 15th, BeiGene announced that its PD-1 product, Terezumab (trade name: Bazeon, T ... -
Renowned pharmaceutical giant announces that a heavyweight new drug has been approved! 1 bottle priced at 100000 yuan, how much impact will it have?
Pharmaceutical giants suddenly transmit significant positive news. On Tuesday Eastern Time, US pharmaceutical giant Merck (MRK, stock price: $131.75; total market value: $333.7 billion) announced tha ... -
Heavyweight new drug approved. Merck's stock price reaches a new historical high, from Wall Street to Lujiazui
The heavyweight new drug has been approved, and Merck's stock price has reached a new historical high. Winrevair expects annual sales of $5 billion for patients with pulmonary arterial hypertension ( ... -
Eli Lilly's new drug for Alzheimer's disease, Kisumla, has been approved by the US FDA
Lilly's new drug for Alzheimer's disease, Kisunla, has been approved by the US FDA. On July 2nd, Lilly announced that the US Food and Drug Administration (FDA) has approved Kisunla for the treatment ... -
Exhibits become commodities in seconds! Prostate cancer new drug approved in China, Pfizer Wang Yu: promoting China's new drug market to synchronize with the global market
On November 5th, the opening day of the 7th CIIE, Pfizer announced that its innovative drug, Terazopanib Tosylate Capsules (trade name: Taizena), has recently been approved for market by the National ... -
Eli Lilly's new Alzheimer's disease drug Donanemab has been approved for pricing in Japan
On November 13th, the Central Social Insurance Medical Agreement, a consulting agency of the Japanese Ministry of Health, Labour and Welfare, approved the official pricing of the new Alzheimer's dise ...